株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国の血液透析産業

Research Report on Hemodialysis Industry in China, 2011-2020

発行 China Research and Intelligence 商品コード 312870
出版日 ページ情報 英文 60 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
中国の血液透析産業 Research Report on Hemodialysis Industry in China, 2011-2020
出版日: 2016年06月01日 ページ情報: 英文 60 Pages
概要

当レポートは、中国における血液透析産業を精査しており、血液透析市場の現況、この市場の成長を左右する経済環境と政策環境、機器および薬剤の供給企業、市場成長促進要因、ならびに市場競争状況を詳細に分析し、今後の市場予測を示しています。また、主要企業についてその経営状況分析を含めた詳細な企業プロファイルを提供し、さらにこの産業における開発および投資についての提言を行っています。

第1章 血液透析産業概要

  • 定義
  • 血液透析機器
  • 血液透析用薬剤
  • 血液透析サービス

第2章 血液透析の世界市場分析

  • 透析グループ
  • 血液透析のカバー率
  • 血液透析機器市場
  • 血液透析サービス市場

第3章 中国における血液透析産業の発達環境

  • 経済環境
  • 政策環境

第4章 中国における血液透析産業の経営状況

  • 末期腎不全患者
    • 末期腎不全患者が必要とする需要量
    • 血液透析を受けている末期腎不全患者の実数
  • 血液透析機器
    • 人工透析装置の市場規模
    • 血液透析装置の市場規模
  • 血液透析用薬剤およびサービス市場
    • 薬剤およびサービスコスト比率
    • 血液透析用薬剤およびサービスの市場規模

第5章 中国における血液透析産業の市場競争状況

  • 参入障壁
    • 政策的障壁
    • 資金的障壁
    • 技術的障壁
  • 業界の市場競争構造
    • 原材料供給企業
    • 客先企業・顧客
    • 業界企業間の競争
    • 新規参入企業

第6章 中国における血液透析機器および薬剤の輸出入分析

  • 輸入分析
    • 透析装置の輸入状況
    • 透析パイプの輸入状況
    • 血液透析液の輸入状況
  • 輸出分析
    • 透析装置の輸出状況
    • 透析パイプの輸出状況
    • 血液透析液の輸出状況

第7章 中国における血液透析市場の主要企業

第8章 中国における血液透析産業見通し

  • 産業発展に影響を与える要因
    • マクロ経済
    • 政府施策
    • 市場の需給
  • 供給予測
    • 血液透析機器供給量予測
    • 血液透析用薬剤およびサービス供給量予測
  • 需要予測
    • 市場規模予測
    • 分野別需要予測
  • 開発および投資についての提言
    • 投資機会について
    • 開発提言

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 1606348

Chronic kidney disease (CKD), namely chronic renal insufficiency or chronic renal failure, refers to chronic kidney structure and function disorder caused by various factors. According to GFR (Glomerular filtration rate) index, chronic kidney disease is divided into five stages. Once the CKD patients enter the fifth stage, namely end-stage renal disease (ESRD) commonly known as uremia, and the renal replacement therapy must be conducted.

Hemodialysis (HD) is one of the renal replacement therapy ways to treat acute or chronic renal failure patients. Presently, there are more than 2 million end-stage renal disease (ESRD) patients all over the world who choose the dialysis therapy, and about 90% of them receive hemodialysis. Because of the high hemodialysis expenses, the dialysis patients mainly concentrate in developed countries. ESRD patients on dialysis account for 10%-20% in developing countries, which is far lower than the 80% in developed countries. The population of dialysis patients is relatively small but fast-growing. In recent years, the annual growth rate of dialysis patients reached over 10% in China, India and Brazil, which was much higher compared to 3%-5% in developed countries.

With the increasing dialysis patients, the number of the global dialysis centers is correspondingly growing, of which the growth rate is consistent with that of dialysis patients. In 2015, the global dialysis centers were estimated to reach 38,000. On average, every dialysis center provided services to 70-80 patients. Based on the relatively high dialysis rate and the slow increase of dialysis patients, it is predicted that the new hemodialysis centers will be constructed in emerging markets of Asia-Pacific regions especially China. Presently, there are a large number of unsatisfied requirements, which will be the significant points of the future dialysis market.

Up to the end of 2015, China had the population of more than 1.37 billion, and ESRD patients surpassed 2 million. Unable to afford it, only a small proportion of end-stage renal disease patients can receive the dialysis therapy. There were 300,000 dialysis patients in China by the end of 2015. The overall dialysis treatment rate was estimated to reach 14%-15% in China, which was lower than the average global level of 38%-40%. It was far lower than the above 90% treatment rate in developed countries. Therefore, there were large development potentials in Chinese dialysis market.

With the improvement of Chinese medical care as well as the increasing income and payment ability of hemodialysis patients, the hemodialysis industry will develop rapidly in the future. Hemodialysis services mainly consist of dialyzers, dialysis consumables, dialysis drugs and labor services. Hemodialysis instruments include dialysis machines, dialyzers and dialysis pipelines. Dialyzers are core consumables with high technical barriers, which accounts for the largest market share. The market size in China exceeded CNY 5 billion while the domestic market share was approximately 30% in 2015. The market size of China's dialysis machines reached about CNY 3 billion in 2015, and the foreign capital brands accounted for 80% of the market share. The hemodialysis powder and fluid are important solvents in the process of hemodialysis. In spite of relatively low technical barriers, domestic enterprises account for over 90% of the market share thanks to the high transport cost (The reasonable transportation radius is no larger than 800 km) and policy barriers. In addition, the market competition is not fierce. Conventional hemodialysis medicines include EPO and heparin which are in general domestically produced. Service costs include costs of bed and health care labors.

Presently, the average hemodialysis expense is about 400-500 CNY for each treatment in China. The gross profit rate of hemodialysis business can universally reach 30-40% or higher. Charges in public hospitals are generally higher than those of private hospitals, of which the gross profits can reach above 50%. According to CRI, there were about 4,000 hemodialysis centers in China up to the end of 2015.

In 2015, the hemodialysis market size exceeded CNY 20 billion with an increase of more than 15% in recent years. The global ESRD patients receiving hemodialysis treatment are estimated to reach 4 million, and those in China will surpass 600,000 accounting for 15%. It is predicted that the overall market size of hemodialysis industry will increase to over CNY 50 billion by 2020.

Through this report, the readers shall acquire the following information:

  • Factors Influencing the Development of Hemodialysis Industry in China
  • Analysis of Hemodialysis Industry Chain in China
  • Analysis of Supply and Demand in China's Hemodialysis Industry
  • Key Enterprises in China's Hemodialysis Industry
  • Market Competition Status in China's Hemodialysis Industry
  • Driving Factors for Development of China's Hemodialysis Market
  • Forecast on Development of China's Hemodialysis Market

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Medical Institutions
  • Manufacturers of Medical Equipment and Drugs
  • Investors and Research Institutions Concerned about Hemodialysis Industry

Table of Contents

1. Related Concepts of Hemodialysis Industry

  • 1.1. Definition
  • 1.2. Hemodialysis Equipment
    • 1.2.1. Hemodialysis Machine
    • 1.2.2. Water Treatment System
    • 1.2.3. Dialyzer
  • 1.3. Hemodialysis Drugs
    • 1.3.1. Hemodialysis Fluid
    • 1.3.2. Antianemia Drugs
    • 1.3.3. Anticoagulant
  • 1.4. Hemodialysis Services

2. Analysis and Forecast of Global Hemodialysis Market

  • 2.1. Dialysis Group
  • 2.2. Coverage Rate of Hemodialysis
  • 2.3. Hemodialysis Equipment Market
  • 2.4. Hemodialysis Service Market

3. Development Environment of Hemodialysis Industry in China, 2011-2020

  • 3.1. Economic Environment
    • 3.1.1. Macro Economy
    • 3.1.2. Resident Income
    • 3.1.3. Medical Industry
  • 3.2. Policy Environment
    • 3.2.1. Industry Policies
    • 3.2.2. Medicare Policies

4. Operation Status of Hemodialysis Industry in China, 2011-2015

  • 4.1. Analysis on Demand
    • 4.1.1. Demand Volume of ESRD Patients
    • 4.1.2. Actual Number of ESRD Patients Receiving Hemodialysis
  • 4.2. Market Size of Hemodialysis Equipment in China, 2011-2015
    • 4.2.1. Market Size of Dialyzers
    • 4.2.2. Market Size of Hemodialysis Machines
  • 4.3. Market Size of Hemodialysis Drugs and Services
    • 4.3.1. Analysis on Costs of Drugs and Services
    • 4.3.2. Market Size of Hemodialysis Drugs

5. Competition Status of Hemodialysis Industry in China, 2011-2016

  • 5.1. Barriers to Entry
    • 5.1.1. Policy Barriers
    • 5.1.2. Capital Barriers
    • 5.1.3. Technical Barriers
  • 5.2. Competition Structure of the Industry
    • 5.2.1. Upstream Suppliers
    • 5.2.2. Downstream Customers
    • 5.2.3. Competition among Enterprises inner the Industry
    • 5.2.4. New Entrants
    • 5.2.5. Substitutes

6. Analysis on Import and Export of Hemodialysis Equipment and Drugs in China, 2011-2015

  • 6.1. Analysis of Import
    • 6.1.1. Import of Dialyzers
    • 6.1.2. Import of Dialysis Tubing
    • 6.1.3. Import of Hemodialysis Fluid
  • 6.2. Analysis of Export
    • 6.2.1. Export of Dialyzers
    • 6.2.2. Export of Dialysis Pipelines
    • 6.2.3. Export of Hemodialysis Fluid

7. Key Enterprises in Hemodialysis industry, 2011-2016

  • 7.1. Fresenius Medical Care
    • 7.1.1. Enterprise Profile
    • 7.1.2. Analysis of Operation Status
  • 7.2. NIPRO Medical Corporation
    • 7.2.1. Enterprise Profile
    • 7.2.2. Analysis of Operation Status
  • 7.3. Baxter International Inc.
    • 7.3.1. Enterprise Profile
    • 7.3.2. Analysis of Operation Status
  • 7.4. Asahi Kasei Medical Co., Ltd.
    • 7.4.1. Enterprise Profile
    • 7.4.2. Analysis of Operation Status
  • 7.5. Shandong Weigao Group Medical Polymer Co., Ltd.

7. 5.1. Enterprise Profile

    • 7.5.2. Analysis of Operation Status
  • 7.6. SWS Hemodialysis Care Co., Ltd.
  • 7.7. Guangdong Biolight Meditech Co., Ltd.
  • 7.8. Sichuan Kelun Pharamceutical Co., Ltd.
  • 7.9. Jihua Medical Apparatus & Instruments Co., Ltd. Guangzhou
  • 7.10. Bain Medical Equipment (Guangzhou) Co., Ltd.
  • 7.11. Zhuhai Hokai Medical Instruments Co., Ltd.

8. Prospect of Hemodialysis Industry in China, 2016-2020

  • 8.1. Factors Influencing Development
    • 8.1.1. Macro Economy
    • 8.1.2. Government Policies
    • 8.1.3. Major Driving Forces
  • 8.2. Forecast on Supply
    • 8.2.1. Forecast on Supply of Hemodialysis Equipment
    • 8.2.2. Forecast on Supply of Hemodialysis Drugs and Services
  • 8.3. Prediction on Demand
    • 8.3.1. Prediction on Market Size
    • 8.3.2. Forecast on Demand in Niche Markets
  • 8.4. Recommendations on Development and Investment
    • 8.4.1. Investment Opportunities
    • 8.4.2. Development Proposals

Selected Charts

  • Chart Estimation of ESRD Dialysis Treatment Rate in Different Countries
  • Chart Global Market Pattern of Dialysis Equipment, 2015
  • Chart Total Medical Expenses in China, 2006-2015
  • Chart Market Size of Hemodialysis Services in China, 2011-2015
  • Chart Market Size of Hemodialyzers in China, 2011-2015
  • Chart Market Size of Hemodialysis Drugs in China, 2011-2015
  • Chart Import Status of Renal Dialysis Equipment in China, 2011-2015
  • Chart Export Status of Renal Dialysis Equipment in China, 2011-2015
  • Chart Operation Status of Fresenius Medical Care, 2011-2015
  • Chart Operation Status of NIPRO Medical Corporation, 2011-2015
  • Chart Operation Status of Shandong Weigao Group Medical Polymer Co., Ltd., 2011-2015
  • Chart Operation Status of Guangdong Biolight Meditech Co., Ltd., 2011-2015
  • Chart Output Volume of Hemodialysis Related Products in Guangdong Biolight Meditech Co., Ltd., 2013-2015
  • Chart Prediction on Market Size of Hemodialysis Services in China, 2016-2020
  • Chart Prediction on Market Size of Hemodialysis Drugs in China, 2016-2020
Back to Top